W5 Report on the high cost of cancer drugs (Canada)

Canada – The CTV investigative journalism program W5 will have a feature on the high cost of cancer drugs in Canada. The show airs tonight, Saturday, March 27th (check your listings) and there will be mention of Revlimid and multiple myeloma. I will post a link to the video once if appears on their website. For now, you can access the W5 website by clicking here.

All 4 parts of Pills, Patients and Profits can be seen here. Two MM patients needing access to thalidomide and Revlimid are featured.